HCW Biologics (HCWB) Other Gross PP&E Adjustments (2020 - 2024)
Historic Other Gross PP&E Adjustments for HCW Biologics (HCWB) over the last 5 years, with Q4 2024 value amounting to $13.1 million.
- HCW Biologics' Other Gross PP&E Adjustments rose 22.49% to $13.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $13.1 million, marking a year-over-year increase of 22.49%. This contributed to the annual value of $13.1 million for FY2024, which is 22.49% up from last year.
- As of Q4 2024, HCW Biologics' Other Gross PP&E Adjustments stood at $13.1 million, which was up 22.49% from $13.1 million recorded in Q4 2023.
- Over the past 5 years, HCW Biologics' Other Gross PP&E Adjustments peaked at $13.1 million during Q4 2024, and registered a low of -$306300.0 during Q1 2022.
- Its 5-year average for Other Gross PP&E Adjustments is $3.9 million, with a median of -$69624.0 in 2023.
- As far as peak fluctuations go, HCW Biologics' Other Gross PP&E Adjustments soared by 36449.62% in 2022, and later grew by 22.49% in 2024.
- HCW Biologics' Other Gross PP&E Adjustments (Quarter) stood at $2.7 million in 2020, then increased by 1.74% to $2.8 million in 2021, then surged by 364.5% to $12.9 million in 2022, then increased by 1.6% to $13.1 million in 2023, then grew by 0.22% to $13.1 million in 2024.
- Its last three reported values are $13.1 million in Q4 2024, $13.1 million for Q4 2023, and -$69624.0 during Q3 2023.